Stay updated on CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Sign up to get notified when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.

Latest updates to the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe update looks like a routine record refresh with no changes to core study elements (eligibility criteria, outcomes, or treatment details). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check34 days agoChange DetectedAdded a prominent government funding notice and a current operating status note, plus a version update to v3.2.0; removed the previous v3.1.0 tag.SummaryDifference3%

- Check41 days agoChange DetectedContent updates expand SIDS-related topics and related pathological terms, and update the revision version from v3.0.2 to v3.1.0.SummaryDifference0.8%

- Check55 days agoChange DetectedPage updated to v3.0.2 (replacing v3.0.1); Back to Top link removed. This is a minor update with no impact on core content or availability.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%

- Check69 days agoChange DetectedThe web page has updated its facility name and location details, specifically adding information about Porto Alegre, Brazil, and various medical conditions, while removing some previous location terms and related topics.SummaryDifference5%

Stay in the know with updates to CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CAMPSIITE™ RGX-121 Gene Therapy in MPS II Clinical Trial page.